Source: Contract Pharma

Fresenius Kabi: Ori Biotech, Fresenius Kabi Partner to Advance Modular Manufacture of CGTs

Integration of Ori's IRO Platform with Cue and Lovo processing systems aim to enhance efficiency in CGT manufacturing.

Read full article »
Est. Annual Revenue
$5.0-10B
Est. Employees
10-50K
Pierluigi Antonelli's photo - President & CEO of Fresenius Kabi

President & CEO

Pierluigi Antonelli

CEO Approval Rating

- -/100

Read more